Free Trial

TriSalus Life Sciences (TLSI) Competitors

TriSalus Life Sciences logo
$4.01
+0.04 (+1.01%)
(As of 11/1/2024 ET)

TLSI vs. BFLY, ZIMV, CLPT, ZJYL, TCMD, NNOX, DCTH, TMCI, ZYXI, and SMTI

Should you be buying TriSalus Life Sciences stock or one of its competitors? The main competitors of TriSalus Life Sciences include Butterfly Network (BFLY), ZimVie (ZIMV), ClearPoint Neuro (CLPT), Jin Medical International (ZJYL), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Zynex (ZYXI), and Sanara MedTech (SMTI). These companies are all part of the "medical equipment" industry.

TriSalus Life Sciences vs.

Butterfly Network (NYSE:BFLY) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Butterfly Network has a beta of 2.18, meaning that its share price is 118% more volatile than the S&P 500. Comparatively, TriSalus Life Sciences has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500.

Butterfly Network presently has a consensus target price of $3.00, indicating a potential upside of 47.78%. TriSalus Life Sciences has a consensus target price of $12.50, indicating a potential upside of 211.72%. Given TriSalus Life Sciences' stronger consensus rating and higher possible upside, analysts plainly believe TriSalus Life Sciences is more favorable than Butterfly Network.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Butterfly Network
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
TriSalus Life Sciences
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17

Butterfly Network has a net margin of -153.29% compared to TriSalus Life Sciences' net margin of -219.71%. TriSalus Life Sciences' return on equity of 0.00% beat Butterfly Network's return on equity.

Company Net Margins Return on Equity Return on Assets
Butterfly Network-153.29% -43.77% -32.05%
TriSalus Life Sciences -219.71%N/A -192.99%

TriSalus Life Sciences received 1 more outperform votes than Butterfly Network when rated by MarketBeat users. Likewise, 100.00% of users gave TriSalus Life Sciences an outperform vote while only 66.67% of users gave Butterfly Network an outperform vote.

CompanyUnderperformOutperform
Butterfly NetworkOutperform Votes
6
66.67%
Underperform Votes
3
33.33%
TriSalus Life SciencesOutperform Votes
7
100.00%
Underperform Votes
No Votes

37.9% of Butterfly Network shares are held by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are held by institutional investors. 27.3% of Butterfly Network shares are held by company insiders. Comparatively, 32.8% of TriSalus Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Butterfly Network had 1 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 7 mentions for Butterfly Network and 6 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 0.65 beat Butterfly Network's score of -0.01 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Butterfly Network
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
TriSalus Life Sciences
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

TriSalus Life Sciences has lower revenue, but higher earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Butterfly Network$65.90M6.55-$133.70M-$0.51-3.98
TriSalus Life Sciences$18.51M6.35-$59.04M-$2.50-1.60

Summary

TriSalus Life Sciences beats Butterfly Network on 11 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLSI vs. The Competition

MetricTriSalus Life SciencesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$117.53M$4.41B$5.40B$8.53B
Dividend YieldN/A42.37%5.13%4.14%
P/E Ratio-1.6038.74115.5615.18
Price / Sales6.3565.071,484.3492.77
Price / CashN/A49.1039.6634.07
Price / Book-4.094.264.665.02
Net Income-$59.04M$11.52M$119.06M$225.46M
7 Day Performance-1.47%1.04%0.80%0.37%
1 Month Performance-9.89%0.92%5.65%3.57%
1 Year Performance-2.43%39.40%36.76%29.44%

TriSalus Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLSI
TriSalus Life Sciences
3.5166 of 5 stars
$4.01
+1.0%
$12.50
+211.7%
-8.2%$117.53M$18.51M-1.60106News Coverage
Gap Up
BFLY
Butterfly Network
2.4107 of 5 stars
$1.82
+3.4%
$3.00
+64.8%
+151.5%$383.49M$71.08M-3.57460Earnings Report
News Coverage
Gap Up
ZIMV
ZimVie
2.4593 of 5 stars
$13.87
-2.0%
$18.33
+32.2%
+108.6%$378.50M$453.38M-1.052,600News Coverage
CLPT
ClearPoint Neuro
0.9281 of 5 stars
$13.04
+3.7%
$11.33
-13.1%
+126.9%$357.56M$28.07M-18.37110Upcoming Earnings
Short Interest ↑
News Coverage
ZJYL
Jin Medical International
N/A$2.18
-3.1%
N/A-76.9%$337.90M$20.13M0.00245Gap Up
TCMD
Tactile Systems Technology
2.5741 of 5 stars
$14.20
+2.1%
$23.00
+62.0%
+25.4%$337.42M$281.54M10.29980Upcoming Earnings
NNOX
Nano-X Imaging
1.1351 of 5 stars
$5.78
+0.9%
$14.00
+142.2%
+13.8%$333.96M$10.13M-5.84190News Coverage
Positive News
DCTH
Delcath Systems
2.654 of 5 stars
$10.68
+0.3%
$21.50
+101.3%
+237.6%$296.75M$11.88M-4.1976Upcoming Earnings
News Coverage
TMCI
Treace Medical Concepts
3.0369 of 5 stars
$4.69
-4.9%
$7.00
+49.3%
-52.7%$290.82M$198.53M-4.60250Upcoming Earnings
News Coverage
ZYXI
Zynex
3.7459 of 5 stars
$9.12
+6.2%
$14.00
+53.5%
-1.5%$289.79M$193.67M50.671,100
SMTI
Sanara MedTech
2.1226 of 5 stars
$31.70
+0.5%
$44.00
+38.8%
+25.5%$273.41M$72.41M-40.6460News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:TLSI) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners